Stifel Financial’s Enzymotec Ltd ENZY Stock Holding History

Stifel Financial’s Portfolio ENZY Stock Details ENZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,768	Closed	-$78K	–	2469
2015 Q1	$78K	Buy	+10,768	New	+$76.2K	﹤0.01%	2212

Other funds holding ENZY

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Stifel Financial's ENZY Position: Q2 2015 in Review

Stifel Financial sold out of Enzymotec Ltd (ENZY) in Q2 2015, closing a stake of 10,768 shares — an estimated $78K sold.

Stifel Financial first reported a position in ENZY in Q1 2015 and held it in 1 quarter. The position peaked at $78K in Q1 2015. 18 funds tracked by Wall St. Rank hold ENZY as of Q2 2015.

Stifel Financial reported no remaining Enzymotec Ltd position as of Q2 2015 after selling out during the quarter.
Stifel Financial sold 10,768 Enzymotec Ltd shares in Q2 2015, an estimated $78K.
Stifel Financial first reported a position in Enzymotec Ltd in Q1 2015 and held it in 1 quarter.
Stifel Financial's Enzymotec Ltd position peaked at $78K in Q1 2015.
18 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2015.

Based on Stifel Financial's 13F filing for Q2 2015, filed 17 Aug 2015.